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Neuropsychiatric disorders are common, complex, and severe
disorders that affect the core of a person: their emotions, intel-
lect, and ability to self-regulate. Millions of individuals world-
wide suffer from these disorders; nevertheless, the factors that
lead to the manifestation of symptoms are poorly understood.
Neuropsychiatric disorders are characterized by heterogeneity,
which means that disorders with similar symptoms and disease
course do not necessarily share the same disease mechanisms or
risk factors. This complex scenario calls for novel and innovative
methodological approaches but also for new hypotheses about
disease mechanisms and disease classifications. The diverse con-
tributions to this research topic reflect various approaches and
opinions in the field of neuropsychiatric genetics and neurode-
generation and could be understood as innovative responses to
the challenges in the research on common complex disorders. The
authors of this special research topic call for the consideration of
genetic and environmental risk factors, and a close attention to
the phenotype. The new focus on rare functional genomic vari-
ants signals recent changes in the perception of common complex
disorders as being not vastly different from rare Mendelian disor-
ders. This shift in perception calls for a reevaluation of common
experimental and statistical approaches and the exploration and
development of novel and less well-established methods.
The five publications summarized under this research topic
address the paradigm shift in common complex disorders in
unique ways. Using personality traits in centennials as an exam-
ple, Bae et al. demonstrate and discuss the analytical and transla-
tional challenges of Genome Wide Association Studies (GWAS)
in common complex disorders brought about by population-
specific allele frequencies, which often hinder the replication of
statistically significant results (Bae et al., 2013). Rogaev highlights
the importance of rare and highly penetrant mutations in gene-
coding regions in familial forms of common complex disorders
and draws attention to the limitations of GWAS in these sce-
narios, using Alzheimer’s disease as an example (Rogaev, 2012).
He also emphasizes the unparalleled opportunities provided by
next-generation sequencing techniques in the search for de novo
mutations in family trios. However, the interpretation of the vast
amount of rare and de novo mutations with unknown functional
consequences, remains challenging. Krebs et al. uses the example
of movement disorders to demonstrate the genetic pleiotropy and
heterogeneity governing the relationship between genotype and
phenotype (Krebs and Paisán-Ruiz, 2012). Pleiotropy refers to the
observation that variations in the same gene can influence several
seemingly unrelated phenotypic traits. Heterogeneity describes
the observation that the same disease can be caused by genetic
variation in any one of a number of genes. The authors also high-
light recent successes in risk gene identification that were brought
about with the help of next-generation sequencing in combi-
nation with linkage studies and/or functional studies in small
animals and cell cultures. Sequeira et al. explore the contributions
of brain-region specific somaticmutations inmitochondrial DNA
in severe psychiatric disorders (Sequeira et al., 2012). And finally,
Brigati et al. present the field of social epigenetics, which explores
how the wiring of our brain is continuously shaped in response
to a constantly changing environment (Brigati et al., 2012). The
researchers contemplate how musical experience could shape and
be vividly retained within our brain, and how it could affect our
behavior.
The multitude of potential disease mechanisms in neuropsy-
chiatric disorders undeniably raises the need for a broad spectrum
of analytical approaches. Therefore, it is encouraging to see the
variety of hypotheses, study designs, and methods in the field of
neuropsychology, as demonstrated in the diverse contributions
to our research topic. While over the past decade the focus has
been on GWAS to detect common genomic variants as risk factors
for neuropsychiatric disorders, the research community is moving
its attention to environmental risk factors and gene-environment
interactions [European Network of National Networks study-
ing Gene-Environment Interactions in Schizophrenia (EU-GEI)
et al., 2014; Wang et al., 2014]. However, funding priorities at the
NIH are only slowly following the trend. Taking schizophrenia
as an example, the percentage of funded projects that focus on
genetic risk factors was 35% in 2011, but only 4% of the funded
proposals studied environmental risk factors, and 0.8% focused
on epigenetics. In 2014, the percentage of funded genetic studies
has declined to 27%, but the percentage of studies with environ-
mental focus also has dropped (to 3%). Funded epigenetic studies
dropped to 0.6% of the portfolio. Despite limited contributions
to our understanding of disease pathomechanisms, grants using
GWAS to identify common genomic risk factors still dominate
and constitute a large portion of the research portfolio at NIH.
The success of a more diversified genetic approach to com-
plex phenotypes, including GWAS, linkage analysis and positional
cloning, candidate gene studies, exome sequencing, and genome
sequencing, has already been demonstrated in, for example, two
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highly co-morbid disorders: amyotrophic lateral sclerosis (ALS)
and frontotemporal lobar degeneration (FTLD; Janssens and
Van Broeckhoven, 2013; Marangi and Traynor, 2014). ALS is a
rare, heterogeneous, complex neurodegenerative disorder, which
affects mostly individuals 65 years of age and older. Genetic
risk factors are believed to explain two-thirds of familial cases
and about 10% of sporadic cases. Environmental risk factors
have also been proposed. So far, a variety of potential genetic
disease mechanisms have been proclaimed, including expansion
repeats, common and rare inherited genetic variations, de novo
mutations, epigenetic changes, somatic mutations, and epista-
sis. FTLD is also a relatively rare, complex, neurodegenerative
disorder. Recent evidence supports the hypothesis that ALS and
FTLD are distinct disorders with unique pathomechanisms and
overlapping phenotypes. In both disorders, the fused-in-sarcoma
(FUS) protein accumulates in the cytosol of neuronal cells in a
subset of cases, but in FTLD the protein is methylated, whereas
in ALS it is not (Dormann et al., 2012). This modification
affects the nuclear import of the protein. A focused approach
on familial cases with autosomal dominant inheritance, and the
use of FUS protein accumulations as a specific neuropathologic
endophenotype present in a subset of cases, led to the identifi-
cation of disease-causing rare mutations in the FUS gene. These
mutations account for about 4% of familial ALS cases (10%).
Disease-causing mutations in sporadic ALS cases (90%) and in
FTLD remain to be discovered (Da Cruz and Cleveland, 2011).
It remains to be seen if similar success can also be accomplished
in common, complex psychiatric disorders, in which GWASs in
increasingly larger population samples have so far dominated
the research portfolio but the identification of disease caus-
ing mutations and the discovery of pathomechanisms remain
elusive.
Hopefully, funding agencies will follow the common trend
toward diversity and encourage novel and creative approaches to
risk factors in neuropsychiatric and neurodegenerative disorders.
In some of the underdeveloped fields of research, standard-
ized approaches and methods will still need to be developed.
In this dynamic process, adherence to solid reporting practices
and independent replication of promising results will be essen-
tial. However, without funding, innovative ideas will remain what
they are—just ideas.
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